CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 29, 2012		Jul. 01, 2011
Cash flows from operating activities:
Net earnings	$ 306,848		$ 298,173
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	36,655		34,912
Tax benefits from exercises of share-based payment awards	6,647		23,597
Excess tax benefits from share-based compensation	(7,805)	[1]	(21,768)	[1]
Depreciation	39,711		36,708
Amortization of intangible assets	2,848		2,280
Deferred taxes	(275)		9,585
Provision for doubtful accounts receivable	6,240		2,065
Income on equity investment in affiliate	(1,225)		(4,488)
Other	(858)		34
Changes in assets and liabilities, net of effect of acquisitions:
Accounts receivable	(4,170)		24,961
Inventories	(49,271)		(68,310)
Prepaid expenses and other current assets	(47,665)		(24,627)
Accounts payable	(7,668)		(2,497)
Accrued expenses	(10,574)		(104)
Deferred revenues	(16,992)		(10,904)
Product warranty	4		(3,615)
Advance payments from customers	54,823		40,935
Other long-term liabilities	(5,911)		(10,010)
Net cash provided by operating activities	301,362		326,927
Cash flows from investing activities:
Purchases of property, plant and equipment	(40,188)		(52,289)
Investment in a privately held company	0		(13,597)
Investment in debt security	(27,950)		0
Acquisition of businesses, net of cash acquired	(28,241)		(8,399)
(Increase) decrease in cash surrender value of life insurance	(2,708)		425
Note repayment from affiliate and other, net	3,360		(7,492)
Other, net	(2,340)		(3,495)
Net cash used in investing activities	(98,067)		(84,847)
Cash flows from financing activities:
Repurchases of common stock	(172,418)		(238,000)
Equity forward contracts	0		(68,063)
Proceeds from issuance of common stock to employees	54,529		132,524
Excess tax benefits from share-based compensation	7,805	[1]	21,768	[1]
Employees' taxes withheld and paid for restricted stock and restricted stock units	(8,598)		(14,188)
Net repayments under line of credit agreements	(12,585)		(20,000)
Repayments of bank borrowings	(9,876)		(5,459)
Other	(74)		(52)
Net cash used in financing activities	(141,217)		(191,470)
Effects of exchange rate changes on cash and cash equivalents	6,851		(2,909)
Net increase in cash and cash equivalents	68,929		47,701
Cash and cash equivalents at beginning of period	564,457	[2]	520,221
Cash and cash equivalents at end of period	$ 633,386		$ 567,922

[1] Amounts represent excess tax benefits from share-based compensation.

[2] The condensed consolidated balance sheet as of September 30, 2011 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.